Eid M, Evin G, Castro B, Menard J, Corvol P
Biochem J. 1981 Aug 1;197(2):465-71. doi: 10.1042/bj1970465.
Four homologues of pepstatin, the potent but poorly soluble inhibitor of aspartic proteinases, were synthesized by coupling to the C-terminus of the natural pentapeptide the following amino acid residues: L-arginine methyl ester, L-aspartic acid, L-glutamic acid and the dipeptide L-aspartyl-L-arginine. The peptide-coupling reagent we used, benzotriazolyloxytris(dimethylamino)phosphonium hexafluorophosphate, allowed us to obtain readily pure pepstatin homologues with high yields (60-83%). Pepstatylarginine methyl ester and pepstatylglutamic acid were about one order of magnitude more water-soluble than pepstatin. The four homologues and pepstatin were tested in vitro as inhibitors for highly purified pig and human renins acting on the N-acetyltetradecapeptide substrate. The 50% inhibitory concentrations (IC50) of the homologues were ranged from 0.01 to 1 microM against porcine renin at pH 6.0 (pepstatin IC50 approximately 0.32 microM) and from 5.8 to 41 microM against human renin at pH 6.5 (pepstatin IC 50 approximately 17 microM). By three different graphical methods we showed that pepstatin and the four homologues behaved as competitive inhibitors for porcine renin. The most potent inhibitors were pepstatylaspartic acid and pepstatylglutamic acid, with inhibitory constants respectively 2- and 10-fold smaller than that of pepstatin. By coupling glutamic acid to pepstatin, the ratio solubility/Ki was increased by two orders of magnitude.
胃蛋白酶抑制剂是天冬氨酸蛋白酶的一种强效但难溶的抑制剂,通过将以下氨基酸残基与天然五肽的C端偶联,合成了四种胃蛋白酶抑制剂的同系物:L-精氨酸甲酯、L-天冬氨酸、L-谷氨酸和二肽L-天冬氨酰-L-精氨酸。我们使用的肽偶联试剂——苯并三唑氧基三(二甲氨基)鏻六氟磷酸盐,使我们能够以高产率(60-83%)轻松获得纯的胃蛋白酶抑制剂同系物。胃蛋白酶抑素精氨酸甲酯和胃蛋白酶抑素谷氨酸的水溶性比胃蛋白酶抑制剂大约高一个数量级。在体外测试了这四种同系物和胃蛋白酶抑制剂对作用于N-乙酰十四肽底物的高度纯化的猪和人肾素的抑制作用。在pH 6.0时,同系物对猪肾素的50%抑制浓度(IC50)范围为0.01至1微摩尔(胃蛋白酶抑制剂IC50约为0.32微摩尔);在pH 6.5时,对人肾素的50%抑制浓度范围为5.8至41微摩尔(胃蛋白酶抑制剂IC50约为17微摩尔)。通过三种不同的图形方法,我们表明胃蛋白酶抑制剂和这四种同系物对猪肾素表现为竞争性抑制剂。最有效的抑制剂是胃蛋白酶抑素天冬氨酸和胃蛋白酶抑素谷氨酸,其抑制常数分别比胃蛋白酶抑制剂小2倍和10倍。通过将谷氨酸与胃蛋白酶抑制剂偶联,溶解度/Ki的比值增加了两个数量级。